查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405834

MicroRNA 市場規模、佔有率和趨勢分析報告：按產品/服務、最終用途、地區和細分市場進行預測，2024-2030 年

MicroRNA Market Size, Share & Trends Analysis Report By Products & Services (Instruments, Consumables), By Application (Cancer, Infectious Diseases) By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

MicroRNA 市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球microRNA市場規模將達到36.4億美元，2024年至2030年複合年成長率為12.87%。

市場開拓是由對開發新型診斷測試和治療方法的研發計劃的大量投資，以及 microRNA 在臨床試驗中的成功整合所推動的。生物製藥板塊在當前生物技術產業中發揮重要作用。生技產業的研發支出大幅增加。多家生物製藥公司正在投資開發基於 RNA 的療法（miRNA 和 siRNA）。主要公司包括 Regulus Therapeutics、Rosetta Genomics、Alnylam Pharmaceuticals、miRagen Therapeutics 和 Mirna Therapeutics。

大量投資，加上政府對 miRNA 研究和開發的資助不斷增加，以開發新的診斷測試和治療方法，預計將推動市場成長。一些新參與企業已經進入市場，採用創新方法開發標靶治療療法和識別藥物研發標靶。例如，在 2022 年 4 月發表在 Elsevier 上的一篇論文中，研究團隊概述了目前的大型隊列研究，證明了循環 miRNA 對於疾病早期診斷的臨床價值。

越來越多的研究調查各種 microRNA 的腫瘤抑製作用，特別是在乳腺癌等細胞株中，正在推動對 microRNA 研究工具的需求不斷增加。此外，基於miRNA的療法在治療各種疾病方面顯示出巨大的潛力，並且不斷發展。將基於 miRNA 的治療藥物精確地遞送至目標細胞仍然是臨床應用的主要挑戰。然而，最近引入的高效遞送系統，例如基於奈米粒子的遞送系統，預計將有助於克服這項挑戰。

MicroRNA 市場報告亮點

  • 按產品/服務分類，服務領域將主導市場，其可提供分離/精製、miRNA cDNA合成、分析、定位、定量和功能分析等廣泛的服務，收益佔有率最高，為58.8%。2023. 做到了。
  • 從應用來看，由於對使用 miRNA 特徵的癌症研究進行了大量投資，腫瘤學領域在 2023 年佔據了最高的收益佔有率。
  • 按最終用途分類，生物技術和製藥公司細分市場將在 2023 年以最高收益佔有率佔據市場主導地位。這是因為我們有能力與研究機構建立合作和夥伴關係，使我們能夠獲得前沿研究並在大型計劃上進行合作。
  • 由於該地區存在主要市場參與者，北美將在 2023 年主導全球產業。

目錄

第1章調查方法與範圍

第 2 章 MicroRNA (miRNA) 市場：執行摘要

  • 市場概述
  • 產品和服務簡介
  • 應用程式和最終使用簡介
  • 競爭形勢概覽

第 3 章 MicroRNA (miRNA) 市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 2019冠狀病毒病爆發
    • miRNA 應用的最新創新
    • 對 miRNA 研究和開發舉措進行大量投資，以開發新的診斷測試和治療方法
    • miRNA在臨床試驗中取得成功
    • 支持核酸研究的技術進步
    • 序列成本指數下降
  • 市場抑制因素分析
    • 與 microRNA套件和其他產品相關的高成本
    • RNA 處理和內部開發 microRNA 檢測方法的挑戰
    • 研究重現性和產品特異性較差
    • 新興市場的生命科學研究基礎設施有限
  • 營商環境分析
    • 波特五力分析
    • PESTLE分析
  • COVID-19 分析

第4章 產品和服務的估算和趨勢分析

  • MicroRNA（miRNA）市場：產品波動分析
  • 裝置
    • 2018-2030 年設備市場估計與預測
    • 科技
    • 工作流程
  • 消耗品
    • 2018-2030 年消耗品市場估計與預測
    • 檢體
    • 工作流程
  • 服務
    • 2018-2030 年服務類型市場估計與預測
    • 分離精製
    • miRNA cDNA 合成
    • 分析、本地化和認證
    • 泛函分析
    • 其他
  • 檢體
    • 2018-2030 年檢體市場估計與預測
    • 全血
    • 血清
    • 電漿
    • FFPE
    • 新鮮冷凍組織
    • 其他

第5章 應用預估/趨勢分析

  • MicroRNA (miRNA) 市場：應用變化分析
  • 癌症
    • 2018-2030年癌症市場收益估算與預測
  • 感染疾病
    • 2018-2030年感染疾病市場收益估計與預測
  • 免疫疾病
    • 2018-2030年免疫疾病市場收益估算與預測
  • 循環系統疾病
    • 2018-2030年循環系統疾病市場收益估算與預測
  • 神經系統疾病
    • 2018-2030年神經系統疾病市場收益估計與預測
  • 其他
    • 2018-2030 年其他市場收益估計與預測

第 6 章 最終用途估算/趨勢分析

  • MicroRNA (miRNA) 市場：最終用途變異分析
  • 生技/製藥公司
    • 2018-2030 年生物技術和製藥公司市場收益估計和預測
  • 學術和政府研究組織
    • 2018-2030 年學術和政府研究機構市場收益估計和預測
  • 其他最終用戶
    • 2018-2030 年其他最終用戶市場收益估計與預測

第7章 區域業務分析

  • 區域市場簡介
  • 北美洲
    • 北美微小RNA
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲微小RNA
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區微小RNA
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 拉丁美洲微小RNA
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 來自中東和非洲的 MicroRNA
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 公司分類
  • 策略規劃
    • 獲得
    • 產品/服務發布
    • 夥伴關係/協作
    • 其他
  • 2023 年市場分析
  • 公司簡介
    • Thermo Fisher Scientififc, Inc
    • QIAGEN
    • Horizon Discovery Group Co.
    • NanoString Technologies, Inc
    • Merck KGaA
    • Takara Bio, Inc
    • LGC Limited
    • BioGenex
    • GeneCopoeia, Inc
    • New England Biolabs
Product Code: GVR-2-68038-368-3

MicroRNA Market Growth & Trends:

The global microRNA market size is expected to reach USD 3.64 billion by 2030, registering a CAGR of 12.87% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is propelled by substantial investments in research and development initiatives for the development of novel diagnostic tests and therapeutics, coupled with the successful integration of microRNAs in clinical trials. The biopharmaceutical sector plays a significant role in the current biotechnology industry. The expenditure on R&D has significantly increased in the biotechnology industry. Several biopharmaceutical companies are investing in the development of RNA-based therapeutics (miRNAs & siRNAs). Some of the major players are Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics.

The substantial investments coupled with increased government funding in miRNA R&D initiatives for the development of new diagnostic tests & therapeutics are anticipated to boost the market growth. Several new players have arrived in the market with innovative approaches for the development of targeted therapeutics and identifying drug targets. For instance, in an article published in Elsevier in April 2022, a team of researchers provided a summary of current large-cohort studies that show the clinical value of circulating miRNAs for the early diagnosis of disease.

The rising number of studies investigating the tumor-suppressive effects of various microRNAs, particularly in cancer cell lines like thoracic cancer, is driving an increased demand for microRNA research tools. Additionally, miRNA-based therapeutics have demonstrated high potential in the treatment of various diseases and are continuously evolving. Accurate delivery of miRNA-based therapeutic agents to the targeted cells remains a major challenge for clinical applications. However, the recent introduction of efficient delivery systems, such as nanoparticle-based delivery systems, is anticipated to help overcome this challenge.

MicroRNA Market Report Highlights:

  • Based on products & services, the services segment dominated the market with the highest revenue share of 58.8% in 2023, due to its ability to provide wide services such as isolation & purification, miRNA cDNA synthesis, profiling, localization, & quantification, functional analysis, and others
  • Based on application, the cancer segment dominated the segment with the highest revenue share in 2023, due to high investments in cancer research adopting miRNA signatures
  • Based on end-use, the biotechnology & pharmaceutical companies segment dominate the market with the highest revenue share in 2023, due to their ability to establish collaborations and partnerships with research institutions that allow them to access cutting-edge research and collaborate on large-scale projects
  • North America dominated the global industry in 2023 owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Products & Service Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End-use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. MicroRNA (miRNA) Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Products and Services Snapshots
  • 2.3. Application and End-use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. MicroRNA (miRNA) Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Outbreak of COVID - 19
    • 3.4.2. Recent innovation in application of miRNAs
      • 3.4.2.1. Increased adoption for use as a biomarker
      • 3.4.2.2. Therapeutic applications
    • 3.4.3. High investments in miRNA R&D initiatives for development of new diagnostic tests & therapeutics
    • 3.4.4. The success of miRNA in clinical trials
    • 3.4.5. Technological advancements to support nucleic acid studies
    • 3.4.6. Exponentially declining cost of sequencing
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost associated with microRNA kits and other products
    • 3.5.2. Challenges in handling RNA & in-house development of assays for microRNA detection
    • 3.5.3. Poor reproducibility of research and specificity of products
    • 3.5.4. Limited life science research infrastructure in emerging markets
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTLE Analysis
  • 3.7. COVID-19 Analysis

Chapter 4. Products & Services Estimates & Trend Analysis

  • 4.1. MicroRNA (miRNA) Market: Products Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Technology
      • 4.2.2.1. Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.2. Real-Time PCR
      • 4.2.2.2.1. Real-Time PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.3. Microarray
      • 4.2.2.3.1. Microarray Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.4. NGS
      • 4.2.2.4.1. NGS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.2.5. Others
      • 4.2.2.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Workflow
      • 4.2.3.1. Workflow Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.2. Isolation & Purification
      • 4.2.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.3. miRNA cDNA Synthesis
      • 4.2.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.4. Profiling, Localization, & Qualification
      • 4.2.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.5. Functional Analysis & Others
      • 4.2.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.6. Others
      • 4.2.3.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Consumables
    • 4.3.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Specimen
      • 4.3.2.1. Specimen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.2. Whole Blood
      • 4.3.2.2.1. Whole Blood Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.3. Serum
      • 4.3.2.3.1. Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.4. Plasma
      • 4.3.2.4.1. Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.5. FFPE
      • 4.3.2.5.1. FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.6. Fresh Frozen Tissue
      • 4.3.2.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.7. Others
      • 4.3.2.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Workflow
      • 4.3.3.1. Workflow Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.2. Isolation & Purification
      • 4.3.3.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.3. miRNA cDNA Synthesis
      • 4.3.3.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.4. Profiling, Localization, & Qualification
      • 4.3.3.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.5. Functional Analysis & Others
      • 4.3.3.5.1. Functional Analysis & Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.6. Others
      • 4.3.3.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Service Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Isolation & Purification
      • 4.4.2.1. Isolation & Purification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. miRNA cDNA Synthesis
      • 4.4.3.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Profiling, Localization, & Qualification
      • 4.4.4.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Functional Analysis
      • 4.4.5.1. Functional Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Specimen
    • 4.5.1. Specimen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Whole Blood
      • 4.5.2.1. Whole Blood Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Serum
      • 4.5.3.1. Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Plasma
      • 4.5.4.1. Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. FFPE
      • 4.5.5.1. FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Fresh Frozen Tissue
      • 4.5.6.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Estimates & Trend Analysis

  • 5.1. MicroRNA (miRNA) Market: Application Movement Analysis
  • 5.2. Cancer
    • 5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Infectious Diseases
    • 5.3.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Immunological Disorder
    • 5.4.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular Disease
    • 5.5.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Neurological Disease
    • 5.6.1. Neurological Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. End-use Estimates & Trend Analysis

  • 6.1. MicroRNA (miRNA) Market: End-use Movement Analysis
  • 6.2. Biotechnology & Pharmaceutical Companies
    • 6.2.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Academic & Government Research Institutes
    • 6.3.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Other End-users
    • 6.4.1. Other End-users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America MicroRNA (miRNA) Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Target Disease Prevalence
      • 7.2.2.5. U.S. MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Target Disease Prevalence
      • 7.2.3.5. Canada MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Target Disease Prevalence
      • 7.3.2.5. UK MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Target Disease Prevalence
      • 7.3.3.5. Germany MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.4. Spain
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Target Disease Prevalence
      • 7.3.4.5. Spain MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Target Disease Prevalence
      • 7.3.5.5. France MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Target Disease Prevalence
      • 7.3.6.5. Italy MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Target Disease Prevalence
      • 7.3.7.5. Denmark Microrna (Mirna) Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Target Disease Prevalence
      • 7.3.8.5. Sweden MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Target Disease Prevalence
      • 7.3.9.5. Norway MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Target Disease Prevalence
      • 7.4.2.5. Japan MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Target Disease Prevalence
      • 7.4.3.5. China MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Target Disease Prevalence
      • 7.4.4.5. India MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Target Disease Prevalence
      • 7.4.5.5. South Korea MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Target Disease Prevalence
      • 7.4.6.5. Thailand MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Target Disease Prevalence
      • 7.4.7.5. Australia MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Target Disease Prevalence
      • 7.5.2.5. Brazil MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Target Disease Prevalence
      • 7.5.3.5. Mexico MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Target Disease Prevalence
      • 7.5.4.5. Argentina MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Target Disease Prevalence
      • 7.6.2.5. South Africa MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Target Disease Prevalence
      • 7.6.3.5. Saudi Arabia MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Target Disease Prevalence
      • 7.6.4.5. UAE MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Target Disease Prevalence
      • 7.6.5.5. Kuwait MicroRNA (miRNA) Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. Acquisition
    • 8.2.2. Product/Service Launch
    • 8.2.3. Partnerships/Collaborations
    • 8.2.4. Others
  • 8.3. Market Position Analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientififc, Inc
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. QIAGEN
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Horizon Discovery Group Co.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. NanoString Technologies, Inc
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Takara Bio, Inc
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. LGC Limited
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. BioGenex
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. GeneCopoeia, Inc
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. New England Biolabs
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 4 Global MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 6 Global MicroRNA Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 9 North America MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 10 North America MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 11 U.S. MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 12 U.S. MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 14 Canada MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 15 Canada MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 Canada MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 17 Europe MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 19 Europe MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Europe MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 21 Germany MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 22 Germany MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Germany MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 24 UK MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 25 UK MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 26 UK MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 27 France MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 28 France MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 France MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 30 Italy MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 31 Italy MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 Italy MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 33 Spain MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 34 Spain MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 35 Spain MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 36 Denmark MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 37 Denmark MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 39 Norway MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 40 Norway MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Norway MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 42 Sweden MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 43 Sweden MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 50 China MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 51 China MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 China MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 53 Japan MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 54 Japan MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Japan MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 56 India MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 57 India MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 India MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 59 South Korea MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 60 South Korea MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 62 Australia MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 63 Australia MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 64 Australia MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 65 Thailand MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 66 Thailand MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 68 Latin America MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 69 Latin America MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Latin America MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 71 Brazil MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 72 Brazil MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 74 Mexico MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 75 Mexico MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 77 Argentina MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 78 Argentina MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa MicroRNA Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 84 South Africa MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 85 South Africa MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 90 UAE MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 91 UAE MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 UAE MicroRNA Market, End-user, 2018 - 2030 (USD Million)
  • Table 93 Kuwait MicroRNA Market, by Products & Services s, 2018 - 2030 (USD Million)
  • Table 94 Kuwait MicroRNA Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait MicroRNA Market, End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Mineral Supplements, Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2023
  • Fig. 15 Global MicroRNA Market: Products & Services Movement Analysis
  • Fig. 16 Global MicroRNA Market, for Products, 2018 - 2030 (USD Million)
  • Fig. 17 Global MicroRNA Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 18 Global MicroRNA Market, for Technology, 2018 - 2030 (USD Million)
  • Fig. 19 Global MicroRNA Market, for Real-Time PCR, 2018 - 2030 (USD Million)
  • Fig. 20 Global MicroRNA Market, for Microarray, 2018 - 2030 (USD Million)
  • Fig. 21 Global MicroRNA Market, for NGS, 2018 - 2030 (USD Million)
  • Fig. 22 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 23 Global MicroRNA Market, for Workflow, 2018 - 2030 (USD Million)
  • Fig. 24 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
  • Fig. 25 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 26 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
  • Fig. 27 Global MicroRNA Market, for Functional Analysis & Others, 2018 - 2030 (USD Million)
  • Fig. 28 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global MicroRNA Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 30 Global MicroRNA Market, for Specimen, 2018 - 2030 (USD Million)
  • Fig. 31 Global MicroRNA Market, for Whole Blood, 2018 - 2030 (USD Million)
  • Fig. 32 Global MicroRNA Market, for Serum, 2018 - 2030 (USD Million)
  • Fig. 33 Global MicroRNA Market, for Plasma, 2018 - 2030 (USD Million)
  • Fig. 34 Global MicroRNA Market, for FFPE, 2018 - 2030 (USD Million)
  • Fig. 35 Global MicroRNA Market, for Fresh Frozen Tissue, 2018 - 2030 (USD Million)
  • Fig. 36 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 37 Global MicroRNA Market, for Workflow, 2018 - 2030 (USD Million)
  • Fig. 38 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
  • Fig. 39 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 40 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
  • Fig. 41 Global MicroRNA Market, for Functional Analysis, 2018 - 2030 (USD Million)
  • Fig. 42 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 43 Global MicroRNA Market, for Services, 2018 - 2030 (USD Million)
  • Fig. 44 Global MicroRNA Market, for Type, 2018 - 2030 (USD Million)
  • Fig. 45 Global MicroRNA Market, for Isolation & Purification, 2018 - 2030 (USD Million)
  • Fig. 46 Global MicroRNA Market, for miRNA cDNA Synthesis, 2018 - 2030 (USD Million)
  • Fig. 47 Global MicroRNA Market, for Profiling, Localization, & Quantification, 2018 - 2030 (USD Million)
  • Fig. 48 Global MicroRNA Market, for Functional Analysis, 2018 - 2030 (USD Million)
  • Fig. 49 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 50 Global MicroRNA Market, for Specimen, 2018 - 2030 (USD Million)
  • Fig. 51 Global MicroRNA Market, for Whole Blood, 2018 - 2030 (USD Million)
  • Fig. 52 Global MicroRNA Market, for Serum, 2018 - 2030 (USD Million)
  • Fig. 53 Global MicroRNA Market, for Plasma, 2018 - 2030 (USD Million)
  • Fig. 54 Global MicroRNA Market, for FFPE, 2018 - 2030 (USD Million)
  • Fig. 55 Global MicroRNA Market, for Fresh Frozen Tissue, 2018 - 2030 (USD Million)
  • Fig. 56 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 57 Global MicroRNA Market: Application Movement Analysis
  • Fig. 58 Global MicroRNA Market, for Cancer, 2018 - 2030 (USD Million)
  • Fig. 59 Global MicroRNA Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 60 Global MicroRNA Market, for Immunological Disorder, 2018 - 2030 (USD Million)
  • Fig. 61 Global MicroRNA Market, for cardiovascular disease, 2018 - 2030 (USD Million)
  • Fig. 62 Global MicroRNA Market, for Neurological Disease, 2018 - 2030 (USD Million)
  • Fig. 63 Global MicroRNA Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 64 Global MicroRNA Market: End-Use Movement Analysis
  • Fig. 65 Global MicroRNA Market, for Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 66 Global MicroRNA Market, for Academic & Government Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 67 Global MicroRNA Market, for Other end-users, 2018 - 2030 (USD Million)
  • Fig. 68 Regional Marketplace: Key Takeaways
  • Fig. 69 Regional Outlook, 2022 & 2030
  • Fig. 70 Global MicroRNA Market: Region Movement Analysis
  • Fig. 71 North America MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 72 U.S. MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 73 Canada MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 74 Europe MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 75 Germany MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 76 UK MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 77 France MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 78 Italy MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 79 Spain MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 80 Denmark MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 81 Norway MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 82 Sweden MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 83 Asia Pacific MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 84 Japan MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 85 China MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 86 India MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 87 Thailand MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 88 Australia MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 89 South Korea MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 90 Latin America MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 91 Brazil MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 92 Mexico MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 93 Argentina MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 94 Middle East and Africa MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 95 South Africa MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 96 Saudi Arabia MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 97 UAE MicroRNA Market, 2018 - 2030 (USD Million)
  • Fig. 98 Kuwait MicroRNA Market, 2018 - 2030 (USD Million)